Compounds > pargyline

pargyline and fluvoxamine

pargyline has been researched along with fluvoxamine in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (16.67)18.2507
2000's3 (50.00)29.6817
2010's2 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM1
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ1
Ekins, S; Williams, AJ; Xu, JJ1
Bär, KI; Feuerstein, TJ; Lücking, CH; Lupp, A1
de Groote, L; Klompmakers, AA; Olivier, B; Westenberg, HG1
Inoue, T; Iwamoto, N; Izumi, T; Kato, A; Kitaichi, Y; Koyama, T1

Other Studies

6 other study(ies) available for pargyline and fluvoxamine

ArticleYear
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
    Toxicology mechanisms and methods, 2008, Volume: 18, Issue:2-3

    Topics:

2008
Developing structure-activity relationships for the prediction of hepatotoxicity.
    Chemical research in toxicology, 2010, Jul-19, Volume: 23, Issue:7

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes

2010
A predictive ligand-based Bayesian model for human drug-induced liver injury.
    Drug metabolism and disposition: the biological fate of chemicals, 2010, Volume: 38, Issue:12

    Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands

2010
Different effects of serotonin (5-HT) uptake blockers in caudate nucleus and hippocampus of the rabbit: role of monoamine oxidase in dopaminergic terminals.
    Psychopharmacology, 1992, Volume: 106, Issue:1

    Topics: Acetylcholine; Animals; Caudate Nucleus; Clomipramine; Depression, Chemical; Dopamine; Female; Fluvoxamine; Hippocampus; In Vitro Techniques; Male; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Nerve Endings; Nomifensine; Pargyline; Pyridazines; Quipazine; Rabbits; Serotonin; Serotonin Antagonists

1992
Role of extracellular serotonin levels in the effect of 5-HT1B receptor blockade.
    Psychopharmacology, 2003, Volume: 167, Issue:2

    Topics: Animals; Autoreceptors; Benzopyrans; Chromatography, High Pressure Liquid; Dose-Response Relationship, Drug; Drug Interactions; Extracellular Space; Fluvoxamine; Frontal Lobe; Male; Microdialysis; Monoamine Oxidase Inhibitors; Morpholines; Pargyline; Potassium Chloride; Rats; Rats, Wistar; Receptor, Serotonin, 5-HT1B; Receptors, Serotonin; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Antagonists; Time Factors

2003
Effects of co-administration of a selective serotonin reuptake inhibitor and monoamine oxidase inhibitors on 5-HT-related behavior in rats.
    European journal of pharmacology, 2006, Feb-27, Volume: 532, Issue:3

    Topics: Analysis of Variance; Animals; Behavior, Animal; Brain; Clorgyline; Dose-Response Relationship, Drug; Drug Synergism; Fluvoxamine; Male; Monoamine Oxidase Inhibitors; Motor Activity; Pargyline; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Selegiline; Serotonin; Serotonin Syndrome

2006